Isotopia USA: Bringing Lu-177 Closer to You with Reliable, Timely Delivery
At our US headquarters in Indianapolis, Indiana, Isotopia is proud to lead the way in the production of Lutetium-177 (Lu-177), a cornerstone in radiopharmaceutical cancer treatments. Our mission is simple: to provide a uniquely enhanced isotope supplier experience for our customers through innovative solutions and exceptional service.
Customer-Centric Focus: Overcoming Logistical Challenges
We understand the challenges associated with isotope delivery, and Isotopia USA is committed to simplifying the process for our clients. By eliminating common logistical frustrations like customs delays, weather-related flight cancellations, and providing real-time tracking, we ensure that our products are delivered on time, every time.
For over 10 years, Isotopia has been a trusted and reliable producer of Lu-177, consistently delivering high-quality products that meet the needs of our many global customers.
State-of-the-Art GMP Manufacturing Facility
Our US-based GMP-compliant facility in the US spans over 30,000 square feet and includes cutting-edge infrastructure:
- Aseptic manufacturing and sterility testing cleanrooms
- Quality Control (QC) and microbiology laboratories
- Raw material labs, waste handling facilities, and engineering labs
This advanced facility enables us to produce and deliver GMP-grade Lu-177 to meet the growing demands of radiopharmaceutical therapies, ensuring the highest standards of safety and quality.
Ready for Commercial-Scale Production
Isotopia USA has already received its radioactive material license from the US Nuclear Regulatory Agency.
By Q3 2025, we will begin producing commercial-scale quantities of GMP-grade Lu-177 nca, allowing customers to qualify their products for process validation and clinical trials
This facility will have the capacity to produce over 200,000 doses per year, ensuring that we can meet, and surpass, the global demand for Lu-177.
Expanding Our Capabilities: Terbium-161 and More
Beyond Lutetium-177, Isotopia USA is expanding its product-list to include Terbium-161 and other groundbreaking isotopes. Additionally, we have achieved the capability to supply finished drug products for pre-clinical, clinical, and commercial manufacturing applications, further solidifying our role as an industry leader in radiopharmaceuticals.
Join Us in Advancing Patient Care
Isotopia USA is committed to transforming cancer treatment with cutting-edge technologies and innovative radiopharmaceuticals. We invite you to discover what Isotopia can offer and let us be your trusted partner in advancing healthcare with the precision and reliability you expect and deserve.
